| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bioblockades join the assault on small G protein signalling
|
Mott, Helen R.
|
|
2019
|
54 |
C |
p. 149-161
|
artikel
|
| 2 |
Blocking Ras inhibition as an antitumor strategy
|
Marín-Ramos, Nagore I.
|
|
2019
|
54 |
C |
p. 91-100
|
artikel
|
| 3 |
Challenges in Ras therapeutics in pancreatic cancer
|
Choi, Minsig
|
|
2019
|
54 |
C |
p. 101-108
|
artikel
|
| 4 |
Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications
|
Imperial, Robin
|
|
2019
|
54 |
C |
p. 14-28
|
artikel
|
| 5 |
Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting
|
Michael, James V.
|
|
2019
|
54 |
C |
p. 121-130
|
artikel
|
| 6 |
Direct inhibition of RAS: Quest for the Holy Grail?
|
Spencer-Smith, Russell
|
|
2019
|
54 |
C |
p. 138-148
|
artikel
|
| 7 |
Editorial Board
|
|
|
2019
|
54 |
C |
p. ii
|
artikel
|
| 8 |
Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis
|
Vivekanandhan, Sneha
|
|
2019
|
54 |
C |
p. 72-79
|
artikel
|
| 9 |
Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
|
Nussinov, Ruth
|
|
2019
|
54 |
C |
p. 114-120
|
artikel
|
| 10 |
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
|
Eibl, Guido
|
|
2019
|
54 |
C |
p. 50-62
|
artikel
|
| 11 |
MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention
|
Karmakar, Saswati
|
|
2019
|
54 |
C |
p. 63-71
|
artikel
|
| 12 |
New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling
|
Erickson, Keesha E.
|
|
2019
|
54 |
C |
p. 162-173
|
artikel
|
| 13 |
New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics
|
Esposito, Dominic
|
|
2019
|
54 |
C |
p. 174-182
|
artikel
|
| 14 |
Oncogenic KRas mobility in the membrane and signaling response
|
Nussinov, Ruth
|
|
2019
|
54 |
C |
p. 109-113
|
artikel
|
| 15 |
P21 activated kinase signaling in cancer
|
Rane, Chetan K.
|
|
2019
|
54 |
C |
p. 40-49
|
artikel
|
| 16 |
Ras and exosome signaling
|
Sexton, Rachel E.
|
|
2019
|
54 |
C |
p. 131-137
|
artikel
|
| 17 |
Ras and Rap1: A tale of two GTPases
|
Shah, Seema
|
|
2019
|
54 |
C |
p. 29-39
|
artikel
|
| 18 |
RAS-mediated oncogenic signaling pathways in human malignancies
|
Khan, Abdul Q.
|
|
2019
|
54 |
C |
p. 1-13
|
artikel
|
| 19 |
Retraction notice to “Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer” [Seminars in Cancer Biology Volume 42, February 2017, Pages 4-12]
|
Shi, Lin
|
|
2019
|
54 |
C |
p. 183
|
artikel
|
| 20 |
Some chinks in RAS armor
|
Azmi, Asfar S.
|
|
2019
|
54 |
C |
p. iii-iv
|
artikel
|
| 21 |
Targeting the RAS-dependent chemoresistance: The Warburg connection
|
Serna-Blasco, Roberto
|
|
2019
|
54 |
C |
p. 80-90
|
artikel
|
Tijdschrift beschrijving